This time around on the pharmaphorum podcast, editor-in-chief Jonah Comstock chats with Nathan Buchbinder, co-founder and chief product officer at Proscia, about pathology data, why it has taken so
The life sciences industry has recently been rocked by dramatic changes in how healthcare is provided, how drugs are developed and researched, the technologies available that enable compani
The use of artificial intelligence (AI) in the biopharma industry has the potential to revolutionise drug discovery and development, as well as improve patient care.
Chinese biotech Hutchmed has completed its rolling marketing application in the US for oral VEGF receptor inhibitor fruquintinib, which was licensed by Takeda for a hefty
